The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version
- PMID: 20832888
- PMCID: PMC3109726
- DOI: 10.1016/j.diabres.2010.08.012
The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version
Abstract
Aims: To translate and examine the psychometric properties of the Malaysian version of the Morisky Medication Adherence Scale (MMAS) among patients with type 2 diabetes.
Methods: A standard "forward-backward" procedure was used to translate MMAS into Malay language. It was later validated on a convenience sample of 223 type 2 diabetes outpatients between May and September 2009. Reliability was tested for internal consistency. Validity was confirmed using convergent and known group validity.
Results: Employing the recommended scoring method, the mean±SD of MMAS scores was 6.13±1.72. Moderate internal consistency was found (Cronbach's α=0.675), the test-retest reliability value was 0.816 (p<0.001). A positive correlation between the eight- and four-item MMAS was found (r=0.792; p<0.01). A significant relationship between MMAS categories and HbA1c categories (χ(2)=20.261; p≥0.001) was found. The MMAS sensitivity and specificity, with positive and negative predictive values were 77.61%, 45.37%, 46.84% and 76.56%, respectively.
Conclusions: The findings of this validation study indicate that the Malaysian version of the MMAS is a reliable and valid measure of medication adherence which can now be used.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
There are no conflicts of interest.
References
-
- International Diabetes Federation. Diabetes atlas. 3. Brussels, Belgium: International Diabetes Federation; 2006.
-
- NHM III. [accessed 23.07.09];The Third National and Morbidity Survey. 2006 Available at http://www.nih.gov.my/NHMS/abstracts_17.html.
-
- UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352:837–53. - PubMed
-
- Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7. - PubMed
-
- Rubin Richard R. Adherence to pharmacologic therapy in patients with Type 2 diabetes mellitus. Am J Med. 2005;118:27S–34S. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
